CNTNAP3P2

Across TCGA pan-cancer cohorts, CNTNAP3P2 RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated CNTNAP3P2 data layer compared with 3 for mutation status.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher CNTNAP3P2 RNA is associated with better overall survival. In most high-consensus cancer types, elevated CNTNAP3P2 expression acts as an unfavorable survival marker, although some lineages such as KIRC and SKCM show a favorable association.

KIRC, ACC, and BLCA are the cancer types where CNTNAP3P2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Tertile	All	0.760	0.552	<.001	121	view →
ACC	OS	Median	All	0.426	0.769	<.001	103	view →
BLCA	OS	Quartile	All	0.504	0.693	<.001	95	view →
THCA	OS	Quartile	All	0.906	1.000	.002	59	view →
SKCM	OS	Median	All	0.480	0.245	<.001	41	view →
LGG	OS	Median	All	0.851	0.935	<.001	39	view →
LUAD	DFS	Tertile	III,IV	0.356	0.578	.010	27	view →
LIHC	OS	Median	II,III,IV	0.286	0.558	.012	24	view →
KIRP	DFS	Tertile	All	0.492	0.762	.001	21	view →
UVM	DFS	Quartile	All	0.360	0.771	.013	17	view →
ESCA	OS	Median	All	1.000	0.693	.038	15	view →
DLBC	DFS	Quartile	III,IV	0.070	0.833	.014	13	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

CNTNAP3P2–KIRC (OS)

Open the KIRC breakdown →